SCHEMBL4192397

SCHEMBL4192397

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc2nsnc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
PKM P14618 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 5/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CCKBR P32239 1/20 0.39
MAPT P10636 7/20 0.38
LMNA P02545 6/20 0.38
TP53 P04637 3/20 0.38
POLB P06746 2/20 0.38
CYP19A1 P11511 1/20 0.36
PKLR P30613 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188260 0.86 PKM (0.43) TSHRPKMKDM4EALDH1A1MEN1
SCHEMBL4191257 0.85 PKM (0.45) PKMKDM4EALDH1A1MEN1KMT2A
SCHEMBL4192361 0.85 GLO1 (0.47) PKMKDM4EALDH1A1MEN1KMT2A
SCHEMBL4194554 0.84 GLO1 (0.46) PKMKDM4EALDH1A1MEN1KMT2A
SCHEMBL4197657 0.83 ALDH1A1 (0.44) TSHRPKMKDM4EALDH1A1KMT2A
SCHEMBL4194915 0.83 ALDH1A1 (0.44) TSHRPKMKDM4EALDH1A1MEN1
SCHEMBL4192565 0.83 KDM4E (0.47) TSHRPKMKDM4EALDH1A1MEN1
SCHEMBL4189882 0.83 MEN1 (0.62) TSHRKDM4EALDH1A1MEN1KMT2A
SCHEMBL4190737 0.83 ALDH1A1 (0.43) TSHRPKMKDM4EALDH1A1MEN1
SCHEMBL4192953 0.83 MAPT (0.47) PKMKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 TSHR 2710/4885PKM 1855/4885KDM4E 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.